HTLV-1
| | | |
|
[12]
|
USA
|
SS-like illness developed in HTLV-I-infected patients with tropical spastic paraparesis.
|
|
[13]
|
Europe
|
An antigen reactive with a monoclonal antibody to HTLV-I p19 was present in the LSG of patients with SS.
|
|
[14]
|
Japan
|
Thirty-six percent of patients with primary SS were found, by ELISA, to be positive for serum antibodies to HTLV-I.
|
|
[15]
|
Japan
|
Rates of HTLV-1 seroprevalence were 23% (17/74) among patients with SS and 3% (916/27,284) among blood donors. However, the difference between patients with systemic lupus erythematosus and blood donors was insignificant.
|
|
[17]
|
Europe
|
Serum antibodies to HTLV-I were detected in 2 to 5 out of 11 patients with SS.
|
|
[18]
|
Japan
|
HTLV-I-infected T cells expressing TCR with a conserved motif accumulated in both HTLV-I-associated and idiopathic SS
|
|
[19]
|
Japan
|
HTLV-I proviral DNA was present in the nucleus of the infiltrating T cells but not in either the epithelial cells or the acinar cells of the salivary glands of HTLV-I-seropositive patients with SS.
|
|
[20]
|
Japan
|
Definitive SS was diagnosed in 6 patients and probable SS in 2 patients among 10 patients with HAM.
|
|
[21]
|
Japan
|
Definite SS was diagnosed in 13 out of 20 patients with HAM.
|
|
[22]
|
Japan
|
The HTLV-I tax gene, but not the HTLV-I gag, pol, or env genes, was detected in LSG samples from 4 out of 14 patients with SS.
|
|
[23]
|
Europe
|
The HTLV-I tax gene, but not the gag, pol, or env genes, was detected in LSG sections from 2 out of 9 patients with SS and from none of the control subjects.
|
|
[24]
|
Europe
|
The tax gene of HTLV-I was detected in LSG from 15 out of 50 of patients (30%) with SS, 9 out of 32 patients (28%) with other inflammatory processes (3/9 graft-versus-host disease, 5/19 extravasated cysts, and 1/4 sarcoidosis), and only 1 out of 26 patients (4%) with normal LSG.
|
|
[25]
|
Japan
|
The HTLV-I tax gene was detected in LSG of 3 out of 17 seronegative patients (18%) with SS.
|
|
[42]
|
USA
|
An autoimmune exocrinopathy with histopathological findings similar to those of SS was observed in HTLV-1 tax transgenic mice.
|
HIV-1
| | | |
|
[27]
|
USA
|
An SS-like illness was reported among HIV-1-infected patients.
|
|
[28, 29]
|
USA
|
The DILS was described as a disorder affecting a subgroup of patients with HIV-1 infection.
|
|
[30]
|
Europe
|
The prevalence of DILS among HIV-1-infected patients was 7.79%.
|
|
[31]
|
USA
|
The prevalence of DILS among HIV-1-infected patients was 32.3%.
|
|
[32]
|
USA-Africa
|
The prevalence of DILS in patients from the US was 6%. The prevalence in patients with HIV infection from Cameroon was 48%.
|
|
[33]
|
Europe
|
The prevalence of HIV-1-related SS dropped from 8% in the pre-HAART era to 1.5% in the post-HAART era.
|
|
[34]
|
USA
|
The prevalence of DILS dropped significantly in the post-HAART era.
|
HIAP-I
| | | |
|
[37]
|
USA
|
HIAP-I has been identified in lymphoblastoid cells cocultured with homogenates of salivary glands from patients with SS.
|
HRV-5
| | | |
|
[40]
|
Europe
|
Novel sequences spanning parts of the protease and reverse transcriptase open reading frames of a retrovirus were detected in LSG tissues of eight patients with SS.
|
|
[41]
|
Europe
|
Two out of 55 LSG samples from patients with SS were positive for HRV-5 proviral DNA.
|